## Teratogenic Risk of Antiepileptic Drugs in Pregnancy **Key Point:** Valproic acid carries the highest teratogenic risk among antiepileptic drugs and is contraindicated in pregnancy, particularly the first trimester. ### Valproic Acid — Mechanism of Teratogenicity Valproic acid causes: - **Neural tube defects** (spina bifida, anencephaly) — 1–2% risk, 10–20× higher than general population - **Developmental delay and autism spectrum disorder** — prenatal exposure linked to cognitive impairment - **Fetal valproate syndrome** — characterized by facial dysmorphism, cardiac defects, skeletal abnormalities, and intellectual disability - **Hepatotoxicity** — fatal hepatic failure in exposed infants **High-Yield:** Valproic acid is a **Category X equivalent** (contraindicated) in pregnancy in most guidelines; if absolutely necessary (intractable seizures), it requires informed consent and high-dose folic acid supplementation (5 mg daily). ### Comparative Safety Profile | Drug | Teratogenic Risk | FDA Category (Legacy) | First Trimester Use | | --- | --- | --- | --- | | **Valproic acid** | Very high (neural tube defects, developmental delay) | X | Contraindicated | | **Lamotrigine** | Low to moderate | C | Relatively safe; preferred | | **Levetiracetam** | Low | C | Safe; increasingly preferred | | **Lacosamide** | Limited data | C | Insufficient evidence; avoid if possible | **Clinical Pearl:** Lamotrigine and levetiracetam are the preferred antiepileptic drugs in women of childbearing age due to low teratogenic risk and good seizure control. ### Management Strategy 1. **Preconception counselling** — switch from valproic acid to safer alternatives (lamotrigine, levetiracetam) before pregnancy 2. **If valproic acid unavoidable** — high-dose folic acid (5 mg daily), informed consent, close monitoring 3. **Seizure control priority** — uncontrolled seizures pose greater risk to fetus than most antiepileptic drugs [cite:KD Tripathi 8e Ch 8]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.